Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-027168
Filing Date
2022-05-04
Accepted
2022-05-04 17:19:18
Documents
1
Period of Report
2022-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5760
  Complete submission text file 0001209191-22-027168.txt   7109
Mailing Address 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address
Shawver Laura (Reporting) CIK: 0001551891 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 22892672

Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations